DreaMed Diabetes utilizes artificial intelligence to analyze patient data and optimize insulin therapy for individuals with diabetes. This approach enhances treatment precision and personalizes support, improving patient outcomes and reducing the risk of complications.
Funding
$3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Managing diabetes requires continuous monitoring of glucose levels and manual adjustments to insulin dosages, which can be time-consuming and prone to errors. Healthcare providers often struggle to efficiently analyze the complex data generated by continuous glucose monitors (CGM) and other diabetes devices to create personalized treatment plans. This can lead to suboptimal glycemic control and increased risk of complications for patients.
Solution
DreaMed Diabetes offers endo.digital, an FDA-cleared AI-powered platform that simplifies diabetes management for both patients and healthcare providers. The platform analyzes data from CGMs, self-monitoring blood glucose (SMBG) devices, and insulin delivery systems to generate personalized treatment recommendations. By automating data analysis and streamlining workflows, endo.digital reduces the time clinicians spend per patient visit and enables more effective insulin management. The platform also integrates seamlessly with electronic medical records (EMR), eliminating the need for manual data entry and improving operational efficiency.
Target Audience
The primary target audience includes endocrinologists, diabetes educators, and other healthcare providers who manage patients with diabetes, as well as hospitals and clinics seeking to improve the efficiency and effectiveness of their diabetes care programs.
Features
- AI-driven analysis of CGM, SMBG, and insulin delivery data
- Personalized insulin dosage recommendations based on patient-specific data
- Seamless EMR integration through Redox partnership
- Automated generation of treatment plans and summaries
- Clinically proven to increase time in range and improve A1C levels
- Unified workflow for data acquisition, interpretation, and documentation
- Support for all types of diabetes and care settings